Large clinical trial will test combination monoclonal antibody therapy for mild/moderate COVID-19
News ReleaseTuesday, January 5, 2021 A Phase 2/3 [...]
News ReleaseTuesday, January 5, 2021 A Phase 2/3 [...]
This interim guidance is intended for organizers and [...]